The global head and neck cancer diagnostics market size is projected to expand at a significant CAGR during the forecast period, 2021–2028. The growth of the market is attributed to rising prevalence of cancer across the globe.
Head and neck cancer are particularly found in people with high alcohol consumption and smoking habit. These types of cancer have high chances of being cured if detected early and treated promptly. The increased frequency of diagnostic procedures for head and neck cancer, especially pharyngeal and oral malignancies, is one of the reasons driving the market expansion. Head & neck cancers include a number of different malignant tumors that develop in or around the throat, sinuses, lips, salivary glands, larynx, nose, and mouth. Head and neck cancer are treated with a variety of medications, which can be used alone or in conjunction.
The COVID-19 pandemic has been declared a public-health emergency by the World Health Organization (WHO). The treatment and diagnosis of patients with head and neck cancer have been severely impacted by the COVID 19 epidemic. The market, on the other hand, is expected to return to normalcy soon and to grow at substantial rate during the forecast period.
Market Trends, Drivers, Restraints, and Opportunities
- Increasing demand for advancements in treatment modes, diagnostic imaging, and incorporating new technologies in diagnostic equipment is estimated to drive the market growth during the forecast period
- Rising intake of tobacco and alcohol products is fueling the demand for the head and neck cancer diagnostics market.
- Increasing support from private and public organizations through investments is estimated to create growth opportunities for the head and neck cancer diagnostics market.
Scope of the Report
The report on the global head and neck cancer diagnostics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes
|
Details
|
Report Title
|
Head and Neck Cancer Diagnostics Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
Base Year
|
2020
|
Historic Data
|
2018–2019
|
Forecast Period
|
2021–2028
|
Segmentation
|
Diagnostic Methods (Endoscopy Screening Equipment, Diagnostic Imaging Equipment, Bioscopy Screening Tests, Dental Diagnostic Methods, Others), and End-users (Diagnostic Centers, and Hospitals)
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
Key Players Covered in the Report
|
Philips; Siemens Healthineers; GE Healthcare; Apteryx Imaging Inc; and Identafi
|
Head and Neck Cancer Diagnostics Market Segment Insights
Diagnostic imaging equipment segment is expected to grow at a rapid pace
Based on diagnostic methods, the market is divided into endoscopy screening equipment, diagnostic imaging equipment, bioscopy screening tests, dental diagnostic methods, others. The diagnostic imaging equipment segment is expected to grow at a rapid pace during the forecast period owing to expanding availability of different types of treatment procedures. increasing spending on diagnostic imaging equipment is expected to boost the segment growth.
Diagnostic centers segment is projected to expand at a considerable CAGR
On the basis of end-users, the market is segregated into diagnostic centers and hospitals. The diagnostic centers segment is projected to expand at a considerable CAGR during the forecast period due to growing concerns towards the patient's health condition and government plans to decrease the cost of treatment.
North America is anticipated to constitute a key market share
In terms of regions, the global head and neck cancer diagnostics market is classified as Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa. North America is expected to constitute a key share of the market during the projected period owing to increasing capital income in both developing and developed countries and the quick acceptance of advanced technologies. However, the market in Latin America is anticipated to expand at a rapid pace during the forecast period due to growing demand for appropriate treatment procedures the diseases.
Segments
The global head and neck cancer diagnostics market has been segmented on the basis of
Diagnostic Methods
- Endoscopy Screening Equipment
- Diagnostic Imaging Equipment
- Bioscopy Screening Tests
- Dental Diagnostic Methods
- Others
End-users
- Diagnostic Centers
- Hospitals
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Philips
- Siemens Healthineers
- GE Healthcare
- Apteryx Imaging Inc
- Identafi
Competitive Landscape
Key players competing in the global head and neck cancer diagnostics market are Philips; Siemens Healthineers; GE Healthcare; Apteryx Imaging Inc; and Identafi.
Industry leaders have built their position in the market by investing more in research and having a superior distribution system.
